Carbamazepine intervention in a patient with efavirenz-induced liver injury.
Sign Up to like & getrecommendations! Published in 2019 at "AIDS"
DOI: 10.1097/qad.0000000000002116
Abstract: In June 2015, a 47-year-old HIV-positive (CD4þ cells: 460/ ml, HIV-1 viral load: 200 000 copies/ml) Caucasian male presented to the clinic because of recently diagnosed HIV. Hewas co-infected with CMVand EBV, and denied alcohol… read more here.
Keywords: induced liver; carbamazepine intervention; efavirenz induced; liver injury ... See more keywords
Efavirenz-Induced Vanishing Bile Duct Syndrome: A Case Report
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Pharmacy Practice"
DOI: 10.1177/0897190019868358
Abstract: Background: Efavirenz (Sustiva®) is used for the treatment of human immunodeficiency virus (HIV) type 1 infection. Hepatoxicity is a known potential adverse drug event with efavirenz; however, to our knowledge, vanishing bile duct syndrome (VBDS),… read more here.
Keywords: efavirenz; case; bile duct; efavirenz induced ... See more keywords